Antenatal Corticosteroids May Contribute to Illness in Children in the Future
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Maggi R, Dondi D, Piccolella M, Casulari L, Martini L
. New insight on the molecular aspects of glucocorticoid effects in nervous system development. J Endocrinol Invest. 2013; 36(9):775-80.
DOI: 10.3275/9003.
View
2.
Astiz M, Heyde I, Fortmann M, Bossung V, Roll C, Stein A
. The circadian phase of antenatal glucocorticoid treatment affects the risk of behavioral disorders. Nat Commun. 2020; 11(1):3593.
PMC: 7367845.
DOI: 10.1038/s41467-020-17429-5.
View
3.
Alexander N, Rosenlocher F, Dettenborn L, Stalder T, Linke J, Distler W
. Impact of Antenatal Glucocorticoid Therapy and Risk of Preterm Delivery on Intelligence in Term-Born Children. J Clin Endocrinol Metab. 2015; 101(2):581-9.
DOI: 10.1210/jc.2015-2453.
View
4.
McKinlay C, Dalziel S, Harding J
. Antenatal glucocorticoids: where are we after forty years?. J Dev Orig Health Dis. 2014; 6(2):127-42.
DOI: 10.1017/S2040174414000579.
View
5.
Oladapo O, Vogel J, Piaggio G, Nguyen M, Althabe F, Gulmezoglu A
. Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries. N Engl J Med. 2020; 383(26):2514-2525.
PMC: 7660991.
DOI: 10.1056/NEJMoa2022398.
View